PMC Links for GEO Profiles (Select 104561270) - PMC

Links from GEO Profiles

Items: 1 to 20 of 301

<< First< Prev

Page of 16

Select item 111597371.

Significance of integrin αvβ5 and erbB3 in enhanced cell migration and liver metastasis of colon carcinomas stimulated by hepatocyte‐derived heregulin

Toshiaki Yoshioka, Yuji Nishikawa, Reiko Ito, Makiko Kawamata, Yuko Doi, Yohei Yamamoto, Masayuki Yoshida, Yasufumi Omori, Hitoshi Kotanagi, Takashi Masuko, Katsuhiko Enomoto

Cancer Sci. 2010 Sep; 101(9): 2011–2018. Published online 2010 Jun 9. doi: 10.1111/j.1349-7006.2010.01640.x

PMCID:: PMC11159737

Abstract Article PDF–704K

Select item 111584262.

Pertuzumab, a novel HER dimerization inhibitor, inhibits the growth of human lung cancer cells mediated by the HER3 signaling pathway

Kazuko Sakai, Hideyuki Yokote, Kimiko Murakami‐Murofushi, Tomohide Tamura, Nagahiro Saijo, Kazuto Nishio

Cancer Sci. 2007 Sep; 98(9): 1498–1503. Published online 2007 Jul 11. doi: 10.1111/j.1349-7006.2007.00553.x

PMCID:: PMC11158426

Abstract Article PDF–406K

Select item 111582903.

Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer

Fusanori Yotsumoto, Tatsuya Fukami, Hiroshi Yagi, Akihiro Funakoshi, Toshiyuki Yoshizato, Masahide Kuroki, Shingo Miyamoto

Cancer Sci. 2010 Nov; 101(11): 2351–2360. Published online 2010 Jul 7. doi: 10.1111/j.1349-7006.2010.01671.x

PMCID:: PMC11158290

Abstract Article PDF–769K

Select item 109168664.

Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma

Suzannah G. Miller, Maria Hoh, Christopher C. Ebmeier, Jian Wei Tay, Natalie G. Ahn

Mol Biol Cell. 2024 Mar 1; 35(3): ar31. Published online 2024 Jan 29. doi: 10.1091/mbc.E23-06-0255

PMCID:: PMC10916866

Abstract Article PDF–4.7M

Select item 109130725.

Targeting HER2/HER3 co‐mutations in metastatic breast cancer: Case reports of exceptional responders to trastuzumab and pertuzumab therapy

Page E. Blas, Esther San Roman Rodriguez, Heather L. Williams, Maren K. Levin, Joshua S. K. Bell, Mariaelena Pierobon, Alexander S. Barrett, Emanuel F. Petricoin, Joyce A. O'Shaughnessy

Cancer Rep (Hoboken) 2024 Mar; 7(3): e1954. Published online 2024 Mar 5. doi: 10.1002/cnr2.1954

PMCID:: PMC10913072

Abstract Article PDF–6.4M

Select item 108201706.

Deciphering the Role of ERBB3 Isoforms in Renal Cell Carcinoma: A Comprehensive Genomic and Transcriptomic Analysis

Mingyu Kim, Hyung Ho Lee, So Dam Won, YeonSue Jang, Baek Gil Kim, Nam Hoon Cho, Young Deuk Choi, Jin Soo Chung, Hyun Ho Han

Medicina (Kaunas) 2024 Jan; 60(1): 181. Published online 2024 Jan 20. doi: 10.3390/medicina60010181

PMCID:: PMC10820170

Abstract Article PDF–2.6M

Select item 105128227.

Role of human epidermal growth factor receptor 3 in treatment resistance of anaplastic lymphoma kinase translocated non-small cell lung cancer

Tiia J Honkanen, Milla E K Luukkainen, Jussi P Koivunen

Cancer Biol Ther. 2023; 24(1): 2256906. Published online 2023 Sep 18. doi: 10.1080/15384047.2023.2256906

PMCID:: PMC10512822

Abstract Article PDF–4.9M

Select item 104072378.

Androgen receptor transcriptional activity is required for heregulin-1β–mediated nuclear localization of the HER3/ErbB3 receptor tyrosine kinase

Maitreyee K. Jathal, Salma Siddiqui, Demitria M. Vasilatis, Blythe P. Durbin Johnson, Christiana Drake, Benjamin A. Mooso, Leandro S. D’Abronzo, Neelu Batra, Maria Mudryj, Paramita M. Ghosh

J Biol Chem. 2023 Aug; 299(8): 104973. Published online 2023 Jun 26. doi: 10.1016/j.jbc.2023.104973

PMCID:: PMC10407237

Abstract Article PDF–5.2M

Select item 102604989.

Downregulation of circ_PLXND1 inhibits tumorigenesis of non‐small cell lung carcinoma via miR‐1287‐5p/ERBB3 axis

Jinzhou Wu, Chenyang Liu, Guiping Yu

Thorac Cancer. 2023 Jun; 14(17): 1543–1555. Published online 2023 Apr 18. doi: 10.1111/1759-7714.14897

PMCID:: PMC10260498

Abstract Article PDF–7.7M

Select item 1019488910.

HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers

Samar M. Alanazi, Wasim Feroz, Rosalin Mishra, Mary Kate Kilroy, Hima Patel, Long Yuan, Sarah J. Storr, Joan T. Garrett

PLoS One. 2023; 18(5): e0285251. Published online 2023 May 18. doi: 10.1371/journal.pone.0285251

Correction in:: PLoS One. 2024; 19(12): e0315773.

PMCID:: PMC10194889

Abstract Article PDF–2.4M

Select item 1017136511.

HER3- A key survival pathway and an emerging therapeutic target in metastatic colorectal cancer and pancreatic ductal adenocarcinoma

Omkar Desai, Rui Wang

Oncotarget. 2023; 14: 439–443. Published online 2023 May 10. doi: 10.18632/oncotarget.28421

PMCID:: PMC10171365

Abstract Article PDF–371K

Select item 1002110512.

MicroRNA-592 Inhibits the Growth of Ovarian Cancer Cells by Targeting ERBB3

Qiong Jin, Ning Zhang, Yang Zhan, Xiaohong Xu, Chao Han, Hui Zhao, Xiaodi Hu, Hongbo Tang, Yumei Wu

Technol Cancer Res Treat. 2023; 22: 15330338231157156. Published online 2023 Mar 14. doi: 10.1177/15330338231157156

PMCID:: PMC10021105

Abstract Article PDF–3.2M

Select item 981142713.

Loci on chromosome 12q13.2 encompassing ERBB3, PA2G4 and RAB5B are associated with polycystic ovary syndrome

R. Alan Harris, Kellie J. Archer, Mark O. Goodarzi, Timothy P. York, Jeffrey Rogers, Andrea Dunaif, Jan M. McAllister, Jerome F Strauss, III

Gene. Author manuscript; available in PMC 2024 Feb 5.

Published in final edited form as: Gene. 2023 Feb 5; 852: 147062. Published online 2022 Nov 21. doi: 10.1016/j.gene.2022.147062

PMCID:: PMC9811427

Abstract Article PDF–642K

Select item 958579414.

HER3 in cancer: from the bench to the bedside

Lucía Gandullo-Sánchez, Alberto Ocaña, Atanasio Pandiella

J Exp Clin Cancer Res. 2022; 41: 310. Published online 2022 Oct 21. doi: 10.1186/s13046-022-02515-x

PMCID:: PMC9585794

Abstract Article PDF–1.6M

Select item 952983015.

Adding of neurotensin to non-small cell lung cancer cells increases tyrosine phosphorylation of HER3

Terry W. Moody, Irene Ramos-Alvarez, Robert T. Jensen

Peptides. Author manuscript; available in PMC 2023 Oct 1.

Published in final edited form as: Peptides. 2022 Oct; 156: 170858. Published online 2022 Aug 3. doi: 10.1016/j.peptides.2022.170858

PMCID:: PMC9529830

Abstract Article PDF–970K

Select item 949894116.

Pan-cancer gene expression analysis of tissue microarray using EdgeSeq oncology biomarker panel and a cross-comparison with HER2 and HER3 immunohistochemical analysis

Koichiro Inaki, Tomoko Shibutani, Naoyuki Maeda, Serenella Eppenberger-Castori, Stefan Nicolet, Yuki Kaneda, Kumiko Koyama, Yang Qiu, Kenichi Wakita, Masato Murakami

PLoS One. 2022; 17(9): e0274140. Published online 2022 Sep 22. doi: 10.1371/journal.pone.0274140

PMCID:: PMC9498941

Abstract Article PDF–2.0M

Select item 934857617.

Chr21 protein–protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer’s disease

Julia Viard, Yann Loe-Mie, Rachel Daudin, Malik Khelfaoui, Christine Plancon, Anne Boland, Francisco Tejedor, Richard L Huganir, Eunjoon Kim, Makoto Kinoshita, Guofa Liu, Volker Haucke, Thomas Moncion, Eugene Yu, Valérie Hindie, Henri Bléhaut, Clotilde Mircher, Yann Herault, Jean-François Deleuze, Jean-Christophe Rain, Michel Simonneau, Aude-Marie Lepagnol-Bestel

Life Sci Alliance. 2022 Dec; 5(12): e202101205. Published online 2022 Aug 1. doi: 10.26508/lsa.202101205